Antioxidant Vitamins and Trace Elements in Critical Illness

Nutrition in Clinical Practice

Volumn 31, Issue 4, 2016, Pages 457-474

  Koekkoek, W A C ^a   Van Zanten, Arthur R H ^a  

^a GELDERSE VALLEI HOSPITAL   (Netherlands)

Author keywords

antioxidants; critical care; critically ill; selenium; trace elements; Vitamin A; Vitamin C; Vitamin E; vitamins; zinc

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; CATALASE; GLUTATHIONE DISULFIDE; RETINOL; SELENIUM; SUPEROXIDE DISMUTASE; THIOREDOXIN REDUCTASE; TRACE ELEMENT; VITAMIN; ZINC;

ADULT RESPIRATORY DISTRESS SYNDROME; ANTIOXIDANT ACTIVITY; CELL DAMAGE; CRITICAL ILLNESS; CRITICALLY ILL PATIENT; DRUG MECHANISM; ENZYME ACTIVITY; HUMAN; MONOTHERAPY; MULTIPLE ORGAN FAILURE; NONHUMAN; OUTCOME ASSESSMENT; OXIDATIVE STRESS; RANDOMIZED CONTROLLED TRIAL (TOPIC); REPERFUSION INJURY; REVIEW; SEPSIS; VITAMIN SUPPLEMENTATION; DIETARY SUPPLEMENT; INTENSIVE CARE; PROCEDURES;

ANTIOXIDANTS; ASCORBIC ACID; CRITICAL CARE; CRITICAL ILLNESS; DIETARY SUPPLEMENTS; HUMANS; SELENIUM; TRACE ELEMENTS; VITAMIN A; VITAMIN E; VITAMINS; ZINC;

EID: 84978663111     PISSN: 08845336     EISSN: 19412452     Source Type: Journal    
DOI: 10.1177/0884533616653832     Document Type: Review

References (118)

1. Betteridge DJ,. What is oxidative stress? Metabolism. 2000; 49: 3-8.
2. Halliwell B,. Free radicals, antioxidants and human disease: curiosity, cause or consequence? Lancet. 1994; 344: 721-724.
3. Pisoschi AM, Pop A,. The role of antioxidants in the chemistry of oxidative stress: a review. Eur J Med Chem. 2015; 97: 55-74.
4. Bernal,. Oxidative stress in critical care medicine. Int J Clin Pract. 2010; 64 (11): 1480-1488.
5. Goodyear-Bruch C, Pierce JD,. Oxidative stress in critically ill patients. Am J Crit Care. 2002; 11 (6): 543-551.
6. Thannickal VJ, Fanburg BL,. Reactive oxygen species in cell signaling. Am J Physiol Lung Cell Mol Physiol. 2000; 279 (6): L1005-1028.
7. Galley HF,. Oxidative stress and mitochondrial dysfunction in sepsis. Br J Anaesth. 2011; 107 (1): 57-64.
8. Gutteridge JM,. Lipid peroxidation and antioxidants as biomarkers of tissue damage. Clin Chem. 1995; 41: 1819-1828.
9. Metnitz PG, Bartens C, Fischer M, Fridrich P, Steltzer H, Druml W,. Antioxidant status in patients with acute respiratory distress syndrome. Intensive Care Med. 1999; 25 (2): 180-185.
10. Abilés J, de la Cruz AP, Castano J, et al. Oxidative stress is increased in critically ill patients according to antioxidant vitamins intake, independent of severity: a cohort study. Crit Care. 2006; 10 (5): R146.
11. Espat NJ, Helton WS,. Oxygen free radicals, oxidative stress, and antioxidants in critical illness. Support Line. 2000; 22: 11-20.
12. Crouser ED,. Mitochondrial dysfunction in septic shock and multiple organ dysfunction syndrome. Mitochondrion. 2004; 4 (5-6): 729-741.
13. Chow CW, Herrera Abreu MT, Suzuki T, Downey GP,. Oxidative stress and acute lung injury. Am J Respir Cell Mol Biol. 2003; 29 (4): 427-431.
14. Quinlan GJ, Lamb NJ, Tilley R, Evans TW, Gutteridge JM,. Plasma hypoxanthine levels in ARDS: implications for oxidative stress, morbidity, and mortality. Am J Respir Crit Care Med. 1997; 155 (2): 479-484.
15. Lenz AG, Jorens PG, Meyer B, et al. Oxidatively modified proteins in bronchoalveolar lavage fluid of patients with ARDS and patients at-risk for ARDS. Eur Respir J. 1999; 13: 169-174.
16. Sarkele M, Sabelnikovs O, Vanags I, Ozolina A, Skesters A, Silova A,. The role of oxidative stress markers in acute respiratory distress syndrome. Acta Chir Latv. 2013; 13 (2): 22-26.
17. Kietzmann D, Kahl R, Müller M, Burchardi H, Kettler D,. Hydrogen peroxide in expired breath condensate of patients with acute respiratory failure and with ARDS. Intensive Care Med. 1993; 19 (2): 78-81.
18. Baldwin SR, Simon RH, Grum Cm, Ketai LH, Boxer LA, Devall LJ,. Oxidant activity in expired breath of patients with adult respiratory distress syndrome. Lancet. 1986; 1 (8471): 11-14.
19. Kalogeris T, Baines CP, Krenz M, Korthuis RJ,. Cell biology of ischemia/reperfusion injury. Int Rev Cell Mol Biol. 2012; 298: 229-317.
20. Zweier JL, Talukder MA,. The role of oxidants and free radicals in reperfusion injury. Cardiovasc Res. 2006; 70 (2): 181-190.
21. Carden DL, Granger DN,. Pathophysiology of ischaemia-reperfusion injury. J Pathol. 2000; 190 (3): 255-266.
22. Xia Z, Chen Y, Fan Q, Xue M, Liu KX,. Oxidative stress-mediated reperfusion injury. Oxid Med Cell Longev. 2015; 2015: 689416.
23. Kalogeris T, Bao Y, Korthuis RJ,. Mitochondrial reactive oxygen species: a double edged sword in ischemia/reperfusion vs preconditioning. Redox Biol. 2014; 2: 702-714.
24. Bray TM, Bettger WJ,. The physiological role of zinc as an antioxidant. Free Radic Biol Med. 1990; 8 (3): 281-291.
25. Formigari A, Irato P, Santon A,. Zinc, antioxidant systems and metallothionein in metal mediated-apoptosis: biochemical and cytochemical aspects. Comp Biochem Physiol C Toxicol Pharmacol. 2007; 146 (4): 443-459.
26. Rizzo AM, Berselli P, Zava S, et al. Endogenous antioxidants and radical scavengers. Adv Exp Med Biol. 2010; 698: 52-67.
27. Mustacich D, Powis G,. Thioredoxin reductase. Biochem J. 2000; 346 (pt 1): 1-8.
28. Lemineur T, Deby-Dupont G, Preiser JC,. Biomarkers of oxidative stress in critically ill patients: what should be measured, when and how? Curr Opin Clin Nutr Metab Care. 2006; 9 (6): 704-710.
29. Crimi E, Sica V, Williams-Ignarro S, et al. The role of oxidative stress in adult critical care. Free Radic Biol Med. 2006; 40 (3): 398-406.
30. Grune T, Berger MM,. Markers of oxidative stress in ICU clinical settings: present and future. Curr Opin Clin Nutr Metab Care. 2007; 10 (6): 712-717.
31. Ho E, Karimi Galougahi K, Liu CC, Bhindi R, Figtree GA,. Biological markers of oxidative stress: applications to cardiovascular research and practice. Redox Biol. 2013; 1: 483-491.
32. Hardy G, Hardy I, Manzanares W,. Selenium supplementation in the critically ill. Nutr Clin Pract. 2012; 27 (1): 21-33.
33. Andrews PJ,. Selenium and glutamine supplements: where are we heading? A critical care perspective. Curr Opin Clin Nutr Metab Care. 2010; 13 (2): 192-197.
34. Burk RF,. Selenium, an antioxidant nutrient. Nutr Clin Care. 2002; 5 (2): 75-79.
35. Hawker FH, Stewart PM, Snitch PJ,. Effects of acute illness on selenium homeostasis. Crit Care Med. 1990; 18 (4): 442-446.
36. Manzanares W, Langlois PL, Heyland DK,. Pharmaconutrition with selenium in critically ill patients: what do we know? Nutr Clin Pract. 2015; 30 (1): 34-43.
37. Bar-Or D, Garrett RE,. Is low plasma selenium concentration a true reflection of selenium deficiency and redox status in critically ill patients? Crit Care Med. 2011; 39 (8): 2000-2001.
38. Tapiero H, Townsend DM, Tew KD,. The antioxidant role of selenium and seleno-compounds. Biomed Pharmacother. 2003; 57: 134-144.
39. Tingii U,. Selenium: its role as antioxidant in human health. Environ Health Prev Med. 2008; 13: 102-108.
40. Manzanares W, Hardy G,. Selenium supplementation in the critically ill: posology and pharmacokinetics. Curr Opin Clin Nutr Metab Care. 2009; 12 (3): 273-280.
41. Fernandes AP, Wallenberg M, Gandin V, et al. Methylselenol formed by spontaneous methylation of selenide is a superior selenium substrate to the thioredoxin and glutaredoxin systems. PLoS One. 2012; 7 (11): e50727.
42. Forceville X, Vitoux D, Gauzit R, Combes A, Lahilaire P, Chappuis P,. Selenium, systemic immune response syndrome, sepsis and outcome in critically ill patients. Crit Care Med. 1998; 26 (9): 1536-1544.
43. Jang JY, Shim H, Lee SH, Lee JG,. Serum selenium and zinc levels in critically ill surgical patients. J Crit Care. 2014; 29 (2): 317.
44. Manzanares W, Biestro A, Galusso F, et al. Serum selenium and glutathioneperoxidase-3 activity: biomarkers of systemic inflammation in the critically ill? Intensive Care Med. 2009; 35 (5): 882-889.
45. Forceville X, Mostert V, Pierantoni A, et al. Selenoprotein P, rather than glutathione peroxidase, as a potential marker of septic shock and related syndromes. Eur Surg Res. 2009; 43 (4): 338-347.
46. Alhazzani W, Jacobi J, Sindi A, et al. The effect of selenium therapy on mortality in patients with sepsis syndrome: a systematic review and meta-analysis of randomized controlled trials. Crit Care Med. 2013; 41 (6): 1555-1564.
47. Huang TS, Shyu YC, Chen HY, et al. Effect of parenteral selenium supplementation in critically ill patients: a systematic review and meta-analysis. PLoS One. 2013; 8 (1): e54431.
48. Kong Z, Wang F, Ji S, Deng X, Xia Z,. Selenium supplementation for sepsis: a meta-analysis of randomized controlled trials. Am J Emerg Med. 2013; 31 (8): 1170-1175.
49. McClave SA, Taylor BE, Martindale RG, et al. Guidelines for the provision and assessment of nutrition support therapy in the adult critically ill patient: Society of Critical Care Medicine (SCCM) and American Society for Parenteral and Enteral Nutrition (A.S.P.E.N.). JPEN J Parenter Enteral Nutr. 2016; 40 (2): 159-211.
50. Allingstrup M, Afshari A,. Selenium supplementation for critically ill adults. Cochrane Database Syst Rev. 2015; 7: CD003703.
51. Landucci F, Mancinelli P, De Gaudio AR, Virgili G,. Selenium supplementation in critically ill patients: a systematic review and meta-analysis. J Crit Care. 2014; 29 (1): 150-156.
52. Critical Care Nutrition. Canadian Clinical Practice Guidelines: 11.2 supplemental antioxidant nutrients: parenteral selenium. 2015. www.criticalcarenutrition.com. Accessed December 28, 2015.
53. Cander B, Dundar ZD, Gul M, Girisgin S,. Prognostic value of serum zinc levels in critically ill patients. J Crit Care. 2011; 26 (1): 42-46.
54. Duncan A, Dean P, Simm M, O'Reilly D, Kinsella J,. Zinc supplementation in intensive care: results of a UK Survey. J Crit Care. 2012; 27: 102. e1-e6.
55. Heyland DK, Jones N, Cvijanovich N, Wong H,. Zinc supplementation in critically ill patients: a key pharmaconutrient? JPEN J Parenter Enteral Nutr. 2008; 32 (5): 509-519.
56. Prasad AS,. Zinc, infection, and immune function. In: Calder PC, Field CJ, Gill HS, eds. Nutrition and Immune Function. New York, NY: CABI; 2002: 193-207.
57. Young B, Ott L, Kasarskis E, et al. Zinc supplementation is associated with improved neurologic recovery rate and visceral protein levels of patients with severe closed head injury. J Neurotrauma. 1996; 13 (1): 25-34.
58. Caldis-Coutris N, Gawaziuk JP, Logsetty S,. Zinc supplementation in burn patients. J Burn Care Res. 2012; 33 (5): 678-682.
59. Kloubert V, Rink L,. Zinc as a micronutrient and its preventive role of oxidative damage in cells. Food Funct. 2015; 6 (10): 3195-3204.
60. Higgins TL, Murray M, Kett DH, et al. Trace element homeostasis during continuous sedation with propofol containing EDTA versus other sedatives in critically ill patients. Intensive Care Med. 2000; 26 (suppl 4): S413-S421.
61. Bao S, Knoell DL,. Zinc modulates cytokine-induced lung epithelial cell barrier permeability. Am J Physiol Lung Cell Mol Physiol. 2006; 291 (6): L1132-L1141.
62. Cruz KJ, de Oliveira AR, Marreiro Ddo N,. Antioxidant role of zinc in diabetes mellitus. World J Diabetes. 2015; 6 (2): 333-337.
63. Oteiza PI,. Zinc and the modulation of redox homeostasis. Free Radic Biol Med. 2012; 53 (9): 1748-1759.
64. Besecker BY, Exline MC, Hollyfield J, et al. A comparison of zinc metabolism, inflammation, and disease severity in critically ill infected and noninfected adults early after intensive care unit admission. Am J Clin Nutr. 2011; 93 (6): 1356-1364.
65. Linko R, Karlsson S, Pettilä V, et al. Serum zinc in critically ill adult patients with acute respiratory failure. Acta Anaesthesiol Scand. 2011; 55 (5): 615-621.
66. Tanumihardjo SA,. Vitamin A: biomarkers of nutrition for development. Am J Clin Nutr. 2011; 94 (2): 658S-665S.
67. Matos AC, Souza GG, Moreira V, Ramalho A,. Effect of vitamin A supplementation on clinical evolution in patients undergoing coronary artery bypass grafting, according to serum levels of zinc. Nutr Hosp. 2012; 27 (6): 1981-1986.
68. D'Ambrosio DN, Clugston RD, Blaner WS,. Vitamin A metabolism: an update. Nutrients. 2011; 3 (1): 63-103.
69. Sies H, Stahl W,. Vitamins E and C, beta-carotene, and other carotenoids as antioxidants. Am J Clin Nutr. 1995; 62 (6)(suppl): 1315S-1321S.
70. World Health Organization. Serum retinol concentrations for determining the prevalence of vitamin A deficiency in populations. 2011. http://www.who.int/vmnis/indicators/retinol.pdf. Accessed December 16, 2015.
71. Nogueira CR, Borges F, Lameu E, Franca C, Ramalho A,. Effects of supplementation of antioxidant vitamins and lipid peroxidation in critically ill patients. Nutr Hosp. 2013; 28 (5): 1666-1672.
72. Biesalski HK,. Comparative assessment of the toxicology of vitamin A and retinoids in man. Toxicology. 1989; 57 (2): 117-161.
73. Stephensen CB, Alvarez JO, Kohatsu J, Hardmeier R, Kennedy JI Jr, Gammon RB Jr,. Vitamin A is excreted in the urine during acute infection. Am J Clin Nutr. 1994; 60 (3): 388-392.
74. Gavrilov V, Weksler N, Ahmed A, Gorodischer R,. Urinary excretion of vitamin A in critically ill patients complicated with acute renal failure. Ren Fail. 2004; 26 (5): 589-590.
75. Christian P, West KP,. Interactions between zinc and vitamin A: an update. Am J Clin Nutr. 1998; 68 (2)(suppl): 435S-441S.
76. Burton GW, Ingold KU,. Beta-carotene: an unusual type of lipid antioxidant. Science. 1984; 224 (4649): 569-573.
77. Corcoran TB, O'Neill MP, Webb SA, Ho KM,. Inflammation, vitamin deficiencies and organ failure in critically ill patients. Anaesth Intensive Care. 2009; 37 (5): 740-747.
78. Bouvier D, Sapin V, Bonnard-Gougeon M, Marceau G,. Retinol potentiates the inhibitory effect of ascorbic acid on uric acid assay. Clin Chem Lab Med. 2010; 48 (5): 693-695.
79. Doise JM, Aho LS, Quenot JP, et al. Plasma antioxidant status in septic critically ill patients: a decrease over time. Fundam Clin Pharmacol. 2008; 22 (2): 203-209.
80. Goode HF, Cowley HC, Walker BE, Howdle PD, Webster NR,. Decreased antioxidant status and increased lipid peroxidation in patients with septic shock and secondary organ dysfunction. Crit Care Med. 1995; 23 (4): 646-651.
81. Nogueira CR, Ramalho A, Lameu E, Da Silva Franca CA, David C, Accioly E,. Serum concentrations of vitamin A and oxidative stress in critically ill patients with sepsis. Nutr Hosp. 2009; 24 (3): 312-317.
82. Mecocci P, Polidori C, Troiano L, et al. Plasma antioxidants and longevity: a study of healthy centenarians. Free Radic Biol Med. 2000; 28 (8): 1243-1248.
83. Berger MM,. Vitamin C requirements in parenteral nutrition. Gastroenterology. 2009; 137 (5)(suppl): S70-S78.
84. Oudemans-van Straaten HM, Spoelstra-de Man AM, de Waard MC,. Vitamin C revisited. Crit Care. 2014; 18 (4): 460.
85. Berger MM, Oudemans-van Straaten HM,. Vitamin C supplementation in the critically ill patient. Curr Opin Clin Nutr Metab Care. 2015; 18 (2): 193-201.
86. Long CL, Maull KI, Krishnan RS, et al. Ascorbic acid dynamics in the seriously ill and injured. J Surg Res. 2003; 109 (2): 144-148.
87. May JM, Harrison FE,. Role of vitamin C in the function of the vascular endothelium. Antioxid Redox Signal. 2013; 19 (17): 2068-2683.
88. May JM,. Vitamin C transport and its role in the central nervous system. Subcell Biochem. 2012; 56: 85-103.
89. Al-Shmgani HS, Moate RM, Macnaughton PD, Sneyd JR, Moody AJ,. Effects of hyperoxia on the permeability of 16HBE14o-cell monolayers-the protective role of antioxidant vitamins E and C. FEBS J. 2013; 280 (18): 4512-4521.
90. Howe KP,. Mechanical Ventilation Antioxidant Trial [dissertation]. Cleveland, OH: Case Western Reserve University; 2005.
91. Borrelli E, Roux-Lombard P, Grau GE, et al. Plasma concentrations of cytokines, their soluble receptors, and antioxidant vitamins can predict the development of multiple organ failure in patients at risk. Crit Care Med. 1996; 24 (3): 392-397.
92. Schorah CJ, Downing C, Piripitsi A, et al. Total vitamin C, ascorbic acid, and dehydroascorbic acid concentrations in plasma of critically ill patients. Am J Clin Nutr. 1996; 63 (5): 760-765.
93. Richard C, Lemonnier F, Thibault M, Couturier M, Auzepy P,. Vitamin E deficiency and lipid peroxidation during adult respiratory distress syndrome. Crit Care Med. 1990; 18 (1): 4-9.
94. Bertrand Y, Pincemail J, Hanique G, et al. Differences in tocopherol-lipid ratios in ARDS and non-ARDS patients. Intensive Care Med. 1989; 15: 87-93.
95. Zanten van AR, Sztark F, Kaisers UX, et al. High-protein enteral nutrition enriched with immune-modulating nutrients vs standard high-protein enteral nutrition and nosocomial infections in the ICU: a randomized clinical trial. JAMA. 2014; 312 (5): 514-524.
96. De Grooth HM, Spoelstra-de Man AME, Oudemans-van Straaten HM,. Early plasma vitamin C concentration, organ dysfunction and ICU mortality. Intensive Care Med. 2014; 40: S199.
97. Hume R, Weyers E, Rowan T, Reid DS, Hillis WS,. Leucocyte ascorbic acid levels after acute myocardial infarction. Br Heart J. 1972; 34 (3): 238-243.
98. Bjordahl PM, Helmer SD, Gosnell DJ,. Perioperative supplementation with ascorbic acid does not prevent atrial fibrillation in coronary artery bypass graft patients. Am J Surg. 2012; 204 (6): 862-867.
99. Sadeghpour A, Alizadehasl A, Kyavar M, et al. Impact of vitamin C supplementation on post-cardiac surgery ICU and hospital length of stay. Anesth Pain Med. 2015; 5 (1): e25337.
100. Fowler AA III, Syed AA, Knowlson S, et al. Phase I safety trial of intravenous ascorbic acid in patients with severe sepsis. J Transl Med. 2014; 12: 32.
101. Lassnigg A, Punz A, Barker R, et al. Influence of intravenous vitamin E supplementation in cardiac surgery on oxidative stress: a doubleblinded, randomized, controlled study. Br J Anaesth. 2003; 90 (2): 148-154.
102. Bartels M, Biesalski HK, Engelhart K, Sendlhofer G, Rehak P, Nagel E,. Pilot study on the effect of parenteral vitamin E on ischemia and reperfusion induced liver injury: a double blind, randomized, placebo-controlled trial. Clin Nutr. 2004; 23 (6): 1360-1370.
103. Traber MG, Atkinson J,. Vitamin E, antioxidant and nothing more. Free Radic Biol Med. 2007; 43 (1): 4-15.
104. Azzi A,. Molecular mechanism of alpha-tocopherol action. Free Radic Biol Med. 2007; 43 (1): 16-21.
105. Bulger EM, Maier RV,. An argument for vitamin E supplementation in the management of systemic inflammatory response syndrome. Shock. 2003; 19 (2): 99-103.
106. Ford ES, Sowell A,. Serum alpha-tocopherol status in the United States population: findings from the Third National Health and Nutrition Examination Survey. Am J Epidemiol. 1999; 150 (3): 290-300.
107. Crimi E, Liguori A, Condorelli M, et al. The beneficial effects of antioxidant supplementation in enteral feeding in critically ill patients: a prospective, randomized, double-blind, placebo-controlled trial. Anesth Analg. 2004; 99 (3): 857-863.
108. Vasilaki AT, Leivaditi D, Talwar D, et al. Assessment of vitamin E status in patients with systemic inflammatory response syndrome: plasma, plasma corrected for lipids or red blood cell measurements? Clin Chim Acta. 2009; 409 (1-2): 41-45.
109. Seeger W, Ziegler A, Wolf HR,. Serum alpha-tocopherol levels after high-dose enteral vitamin E administration in patients with acute respiratory failure. Intensive Care Med. 1987; 13 (6): 395-400.
110. Durant R, Klouche K, Delbosc S, et al. Superoxide anion overproduction in sepsis: effects of vitamin E and simvastatin. Shock. 2004; 22 (1): 34-39.
111. Howe KP, Clochesy JM, Goldstein LS, Owen H,. Mechanical Ventilation Antioxidant Trial. Am J Crit Care. 2015; 24 (5): 440-445.
112. Nathens AB, Neff MJ, Jurkovich GJ, et al. Randomized, prospective trial of antioxidant supplementation in critically ill surgical patients. Ann Surg. 2002; 236 (6): 814-822.
113. Manzanares W, Dhaliwal R, Jiang X, Murch L, Heyland DK,. Antioxidant micronutrients in the critically ill: a systematic review and meta-analysis. Crit Care. 2012; 16 (2): R66.
114. Andrews PJ, Avenell A, Noble DW, et al. Randomised trial of glutamine, selenium, or both, to supplement parenteral nutrition for critically ill patients. BMJ. 2011; 342: d1542.
115. Heyland D, Muscedere J, Wischmeyer PE, et al. A randomized trial of glutamine and antioxidants in critically ill patients. N Engl J Med. 2013; 368 (16): 1489-1497.
116. Heyland DK, Elke G, Cook D, et al. Glutamine and antioxidants in the critically ill patient: a post hoc analysis of a large-scale randomized trial. JPEN J Parenter Enteral Nutr. 2015; 39 (4): 401-409.
117. Brealey D, Brand M, Hargreaves I, et al. Association between mitochondrial dysfunction and severity and outcome of septic shock. Lancet. 2002; 360 (9328): 219-223.
118. Mashour S, Turner JF Jr, Merrell R,. Acute renal failure, oxalosis, and vitamin C supplementation: a case report and review of the literature. Chest. 2000; 118: 561-563.